Abivax shares sink after key trial results for inflammatory bowel drug

Abivax SA

02/06/2026 08:19

       June 2 (Reuters) - Abivax  ABVX.PA  shares tumbled 26%
on Tuesday after the French biotech company unveiled the highly
anticipated results of the late-stage trial for its inflammatory
bowel drug the night before.

(Reporting by Gianluca Lo Nostro; Editing by Milla
Nissi-Prussak)
((mailto:gianluca.lonostro@thomsonreuters.com;))